Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain

NCT07008703 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer Pain

Interventions

DRUG: Injection of humanized nerve growth factor (NGF) antibody

Sponsor

Shenyang Sunshine Pharmaceutical Co., LTD.